CIK 0001088856 · Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770487658
- Phone
- 650.688.8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,067,988
- in 15 filings, $36.6M under 10b5-1 plans
Net −$41,067,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-01 | Maduck Sean See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −25,000 | 141,986 | ||
| 2026-06-01 | Mokari Atabak Chief Financial Officer | Option exercise 10b5-1 | +40,000 | $19.26 | $770K | 55,257 |
| 2026-06-01 | Mokari Atabak Chief Financial Officer | Sale 10b5-1 | −40,000 | $70.00 | $2.8M | 15,257 |
| 2026-06-01 | Mokari Atabak Chief Financial Officer | Grant or award 10b5-1 | +634 | $70.44 | $45K | 15,891 |
| 2026-06-01 | Mokari Atabak Chief Financial Officer | Grant or award 10b5-1 | +634 | 16,525 | ||
| 2026-06-01 | Mokari Atabak Chief Financial Officer | Option exercise · Stock option (right to buy) 10b5-1 | −40,000 | 60,000 | ||
| 2026-06-01 | Robb Gary Charles Chief Business Officer | Grant or award | +776 | $70.44 | $55K | 25,263 |
| 2026-06-01 | Robb Gary Charles Chief Business Officer | Grant or award | +776 | 26,039 | ||
| 2026-06-01 | BELANOFF JOSEPH K Chief Executive Officer | Sale 10b5-1 | −12,837 | $69.74 | $895K | 2,565,489 |
| 2026-05-29 | BELANOFF JOSEPH K Chief Executive Officer | Gift 10b5-1 | −300,000 | 2,578,326 | ||
| 2026-05-29 | BELANOFF JOSEPH K Chief Executive Officer | Gift 10b5-1 | +150,000 | 150,000 | ||
| 2026-05-29 | BELANOFF JOSEPH K Chief Executive Officer | Gift 10b5-1 | +150,000 | 150,000 | ||
| 2026-05-27 | Robb Gary Charles Chief Business Officer | Gift | −600 | 25,081 | ||
| 2026-05-27 | Lyon Joseph Douglas See Remarks | Sale | −5,000 | $65.00 | $325K | 6,230 |
| 2026-05-27 | Maduck Sean See Remarks | Option exercise 10b5-1 | +75,000 | $8.27 | $620K | 83,977 |
| 2026-05-27 | Maduck Sean See Remarks | Sale 10b5-1 | −54,575 | $65.37 | $3.6M | 29,402 |
| 2026-05-27 | Maduck Sean See Remarks | Sale 10b5-1 | −20,425 | $66.16 | $1.4M | 8,977 |
| 2026-05-27 | Maduck Sean See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −75,000 | 166,986 | ||
| 2026-05-27 | WILSON JAMES N Director | Gift | −892,056 | 9,011 | ||
| 2026-05-27 | WILSON JAMES N Director | Gift | −9,011 | 0 |
Page 10 of 61 · 1,220 trades